Senior insider sale
Chief Scientific Officer at CARTESIAN THERAPEUTICS, INC. — senior position signals high conviction
$282.8K
37.45K shares
What this filing means
JEWELL CHRISTOPHER M plans to sell 37.45K shares of CARTESIAN THERAPEUTICS, INC. valued at approximately $282.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/13/2026ACC: 0001950047-26-000366
Officer· Chief Scientific Officer
Since Nov 2023
37.45K
Shares to sell
$282.8K
Approx. market value
9K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
1/10/2025
9KTotal acquired9K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/10/2025 | Exercise of options under a registered plan Cash | 9K | — |
| Total | 9K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10.51K
Market value
$84.3K
1/9/2026
—Completed
Units to sell
17.93K
Market value
$129.6K
11/19/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
9K
Market value
$68.9K
1/13/2026
Total
Units
37.45K
Value
$282.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/9/2026 | 10.51K | $84.3K | — | Completed |
11/19/2025 | 17.93K | $129.6K | — | Completed |
| Planned — Approximate Date | ||||
1/13/2026 | 9K | $68.9K | NASDAQ | Planned |
| Total | 37.45K | $282.8K | ||